Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes.

Diabetes technology & therapeutics·2026
Same author

The glucose monitoring comparison in primary care study (GluCoCare): Study design, methods, recruitment success, and baseline characteristics of study participants.

Contemporary clinical trials·2026
Same author

Genital Pyoderma Gangrenosum: A Systematic Review of Reported Cases and Treatment Outcomes.

Journal of cutaneous medicine and surgery·2026
Same author

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Diabetes technology & therapeutics·2026
Same author

Updated glucose management indicator (GMI) better aligns with HbA<sub>1c</sub> than current GMI: implications for clinical practice and reporting.

Diabetologia·2026
Same author

Merging T1D and T2D Management: Shared Strategies for Common Goals-Building on Early Lessons From GLP-1 Trials in T1D.

Diabetes care·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
Same journal

Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Continuous Glucose Monitoring and Hypoglycemia Detection while Driving: Results from a Cross-Sectional Survey.

Diabetes technology & therapeutics·2026
Same journal

<i>Erratum to:</i> "HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis".

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> Comments on: Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States.

Diabetes technology & therapeutics·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Real-World Ketone Testing Patterns Among People Using FreeStyle Libre.

Richard M Bergenstal1, Naunihal Virdi2, Farhan Quadri2

  • 1International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.

Diabetes Technology & Therapeutics
|May 11, 2026
PubMed
Summary
This summary is machine-generated.

Most FreeStyle Libre users rarely test ketones, even with high glucose. Ketone testing is often delayed and retesting is infrequent, indicating poor adherence to monitoring guidelines.

Keywords:
FreeStyle Librediabetic ketoacidosisglucose monitoringketone monitoringreal-world data

More Related Videos

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
06:55

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

Area of Science:

  • Endocrinology
  • Diabetes Management
  • Metabolic Monitoring

Background:

  • Ketone testing is crucial for managing diabetes, especially during hyperglycemia.
  • Current ketone testing behaviors and their relation to glucose control are not well understood.

Purpose of the Study:

  • To describe ketone testing patterns in individuals using FreeStyle Libre (FSL) readers.
  • To assess glucose control in relation to ketone testing in a real-world dataset.

Main Methods:

  • Analysis of over 2.5 million historical glucose and ketone readings from FSL users.
  • Categorization of ketone excursions and evaluation of glucose levels 24 hours pre- and post-ketone testing.
  • Assessment of ketone test frequency and retesting within 72 hours.

Main Results:

  • 92.4% of users never performed a ketone test; only 5% tested when glucose exceeded 250 mg/dL.
  • Elevated ketones (≥3.0 mmol/L) were associated with higher preceding glucose levels.
  • Testing for ketones ≥1.5 mmol/L was delayed by 5-8 hours after glucose exceeded 250 mg/dL; retesting was rare.

Conclusions:

  • Most FSL users do not adhere to standard-of-care recommendations for ketone monitoring.
  • Current ketone testing methods have limitations in adherence and timely retesting.
  • Continuous ketone monitoring integration could improve adherence and address current testing limitations.